Sling Therapeutics, Inc.
A clinical-stage biotechnology company developing an oral drug candidate for thyroid eye disease.
$123MSeries C
ParticipantLoading investors…
Activity from announced rounds
A clinical-stage biotechnology company developing an oral drug candidate for thyroid eye disease.